Cases 21 - 30 of 262
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv02608
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
CUBIST PHARMACEUTICALS LLC v. MYLAN PHARMACEUTICALS INC. et al
as 2:2020cv03168
Plaintiff:
CUBIST PHARMACEUTICALS LLC
Defendant:
MYLAN INC., MYLAN PHARMACEUTICALS INC. and MYLAN N.V.
Cause Of Action: 35 U.S.C. § 271
BAUSCH HEALTH US, LLC et al v. MYLAN PHARMACEUTICALS INC. et al
as 3:2020cv02749
Plaintiff:
BAUSCH HEALTH IRELAND LIMITED, KAKEN PHARMACEUTICAL CO., LTD., BAUSCH HEALTH US, LLC and others
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN LABORATORIES LTD.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. MYLAN PHARMACEUTICALS INC. et al
as 2:2019cv22231
Plaintiff:
CELGENE CORPORATION
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN INC. and MYLAN N.V.
Cause Of Action: 15 U.S.C. § 1126
AMGEN INC et al v. MYLAN INC. et al
as 2:2017cv01235
Defendant:
MYLAN GMBH, MYLAN PHARMACEUTICALS INC, MYLAN INC. and others
Plaintiff:
AMGEN INC and AMGEN MANUFACTURING LIMITED
Petitioner:
HOSPIRA, INC.
Cause Of Action: 35 U.S.C. § 271
Celgene Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00003
Plaintiff:
Celgene Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan, N.V.
Cause Of Action: 35 U.S.C. § 145
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
